Copper(I) targeting in the Alzheimer's disease context: a first example using the biocompatible PTA ligand.
Atrián-Blasco, E
Copper(I) targeting in the Alzheimer's disease context: a first example using the biocompatible PTA ligand. [electronic resource] - Metallomics : integrated biometal science Aug 2015 - 1229-32 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1756-591X
10.1039/c5mt00077g doi
Adamantane--analogs & derivatives
Alzheimer Disease--drug therapy
Amyloid beta-Peptides--chemistry
Copper--isolation & purification
Humans
Organophosphorus Compounds--pharmacology
Oxidation-Reduction
Reactive Oxygen Species--metabolism
Copper(I) targeting in the Alzheimer's disease context: a first example using the biocompatible PTA ligand. [electronic resource] - Metallomics : integrated biometal science Aug 2015 - 1229-32 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1756-591X
10.1039/c5mt00077g doi
Adamantane--analogs & derivatives
Alzheimer Disease--drug therapy
Amyloid beta-Peptides--chemistry
Copper--isolation & purification
Humans
Organophosphorus Compounds--pharmacology
Oxidation-Reduction
Reactive Oxygen Species--metabolism